Business Context and Reporting Period
Company: CollPlant Biotechnologies Ltd.
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Date: July 28, 2026
Context: The filing announces an Extraordinary General Meeting of Shareholders scheduled for August 18, 2026, in Tel-Aviv, Israel. The document serves to provide the Notice and Proxy Statement and a Proxy Card for shareholder voting.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a procedural filing regarding a shareholder meeting and does not contain financial statements or performance data.
Material Changes
No material financial changes versus a prior comparable period are reported in this document.
Guidance, Outlook, and Management Commentary
Upcoming Event: An Extraordinary General Meeting will be held on August 18, 2026, at 10:00 a.m. Israel time at the offices of Goldfarb Gross Seligman & Co. in Tel-Aviv.
Shareholder Action: Shareholders are provided with a Notice and Proxy Statement (Exhibit 99.1) and a Proxy Card (Exhibit 99.2) to vote on proposals to be presented at the meeting.
Management Commentary: The filing contains no specific commentary on business outlook, risks, or contingencies beyond the procedural details of the meeting.
Key Facts for Investor Verification
- Verify the specific proposals to be voted upon in the attached Notice and Proxy Statement (Exhibit 99.1), as the summary text does not detail the agenda items.
- Confirm the voting deadline and procedures for submitting proxies if not attending the meeting in person on August 18, 2026.
- Note that this filing does not update the company's financial status or operational results.